| Q46189476 | A Novel Biomimetic Nanosponge Protects the Retina from the Enterococcus faecalis Cytolysin |
| Q21131553 | A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule |
| Q56769860 | Allicin reduces the production of α-toxin by Staphylococcus aureus |
| Q93081876 | An Eye on Staphylococcus aureus Toxins: Roles in Ocular Damage and Inflammation |
| Q37832951 | Animal models of bacterial keratitis |
| Q24650729 | Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia |
| Q35609664 | Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence |
| Q47107858 | Atopic keratoconjunctivitis with corneal ulcer. Case report |
| Q33906155 | Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions |
| Q34855656 | Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis |
| Q34200320 | Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia |
| Q90115200 | Contribution of anti-inflammatory and anti-virulence effects of azithromycin in the treatment of experimental Staphylococcus aureus keratitis |
| Q34132134 | Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis |
| Q54513922 | Corneal ulceration and episcleritis associated with Wiskott-Aldrich syndrome. |
| Q34558673 | Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment. |
| Q33552970 | Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses |
| Q39514553 | Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro |
| Q64054784 | Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections |
| Q33453927 | Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma |
| Q28485590 | Global transcriptome analysis of Staphylococcus aureus response to hydrogen peroxide |
| Q41599838 | Histopathological Studies on Rabbits Infected by Bacteria Causing Infectious Keratitis in Human through Eye Inoculation |
| Q35558127 | Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins |
| Q39537000 | Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis |
| Q35138940 | In vitro selection of single-stranded DNA molecular recognition elements against S. aureus alpha toxin and sensitive detection in human serum |
| Q37152357 | Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion |
| Q35590415 | Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors |
| Q37229481 | Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity |
| Q34938184 | Moxifloxacin Efficacy and Vitreous Penetration in a Rabbit Model ofStaphylococcus aureusEndophthalmitis and Effect on Gene Expression of Leucotoxins and Virulence Regulator Factors |
| Q24520487 | Natural pathogens of laboratory mice, rats, and rabbits and their effects on research |
| Q33910565 | Novel targeted immunotherapy approaches for staphylococcal infection. |
| Q35651831 | Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells |
| Q35231357 | Pathogenesis of contact lens-associated microbial keratitis |
| Q41024651 | Pharmacokinetic considerations in the treatment of bacterial keratitis |
| Q39791076 | Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative |
| Q46779215 | Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. |
| Q39156160 | Proteomics in the Study of Bacterial Keratitis |
| Q21136345 | Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase |
| Q34346202 | Role of pore-forming toxins in bacterial infectious diseases |
| Q36848321 | Role of pore-forming toxins in neonatal sepsis |
| Q35546006 | Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. |
| Q33938600 | Staphylococcus aureus Biofilm and Planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes |
| Q92043902 | Staphylococcus aureus alpha-hemolysin impairs corneal epithelial wound healing and promotes intracellular bacterial invasion |
| Q38784468 | Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2 |
| Q42117524 | Staphylococcus aureus protein A induced inflammatory response in human corneal epithelial cells |
| Q47213929 | The Pathogenesis of Staphylococcus aureus Eye Infections |
| Q37072625 | The exosporium of B. cereus contains a binding site for gC1qR/p33: implication in spore attachment and/or entry |
| Q46836367 | The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits |
| Q34058980 | The psmα locus regulates production of Staphylococcus aureus alpha-toxin during infection |